ID   PXDN_HUMAN              Reviewed;        1479 AA.
AC   Q92626; A8QM65; D6W4Y0; Q4KMG2;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Peroxidasin homolog;
DE            EC=1.11.1.7;
DE   AltName: Full=Melanoma-associated antigen MG50;
DE   AltName: Full=Vascular peroxidase 1;
DE   AltName: Full=p53-responsive gene 2 protein;
DE   Flags: Precursor;
GN   Name=PXDN; Synonyms=KIAA0230, MG50, PRG2, VPO, VPO1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10441517; DOI=10.1006/bbrc.1999.1123;
RA   Horikoshi N., Cong J., Kley N., Shenk T.;
RT   "Isolation of differentially expressed cDNAs from p53-dependent
RT   apoptotic cells: activation of the human homologue of the Drosophila
RT   peroxidasin gene.";
RL   Biochem. Biophys. Res. Commun. 261:864-869(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=11103812;
RA   Mitchell M.S., Kan-Mitchell J., Minev B., Edman C., Deans R.J.;
RT   "A novel melanoma gene (MG50) encoding the interleukin 1 receptor
RT   antagonist and six epitopes recognized by human cytolytic T
RT   lymphocytes.";
RL   Cancer Res. 60:6448-6456(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), 3D-STRUCTURE MODELING,
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, HEME
RP   COFACTOR, AND TISSUE SPECIFICITY.
RX   PubMed=18929642; DOI=10.1016/j.freeradbiomed.2008.09.009;
RA   Cheng G., Salerno J.C., Cao Z., Pagano P.J., Lambeth J.D.;
RT   "Identification and characterization of VPO1, a new animal heme-
RT   containing peroxidase.";
RL   Free Radic. Biol. Med. 45:1682-1694(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-1479 (ISOFORM 2).
RC   TISSUE=Chondrosarcoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1176 AND SER-1180, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [8]
RP   SUBCELLULAR LOCATION.
RA   Cheng G.;
RL   Unpublished observations (FEB-2008).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INDUCTION BY TGFB1.
RX   PubMed=19590037; DOI=10.2353/ajpath.2009.080693;
RA   Peterfi Z., Donko A., Orient A., Sum A., Prokai A., Molnar B.,
RA   Vereb Z., Rajnavolgyi E., Kovacs K.J., Muller V., Szabo A.J.,
RA   Geiszt M.;
RT   "Peroxidasin is secreted and incorporated into the extracellular
RT   matrix of myofibroblasts and fibrotic kidney.";
RL   Am. J. Pathol. 175:725-735(2009).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1178.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   INVOLVEMENT IN ASGD7, AND VARIANT ASGD7 CYS-880.
RX   PubMed=21907015; DOI=10.1016/j.ajhg.2011.08.005;
RA   Khan K., Rudkin A., Parry D.A., Burdon K.P., McKibbin M., Logan C.V.,
RA   Abdelhamed Z.I., Muecke J.S., Fernandez-Fuentes N., Laurie K.J.,
RA   Shires M., Fogarty R., Carr I.M., Poulter J.A., Morgan J.E.,
RA   Mohamed M.D., Jafri H., Raashid Y., Meng N., Piseth H., Toomes C.,
RA   Casson R.J., Taylor G.R., Hammerton M., Sheridan E., Johnson C.A.,
RA   Inglehearn C.F., Craig J.E., Ali M.;
RT   "Homozygous mutations in PXDN cause congenital cataract, corneal
RT   opacity, and developmental glaucoma.";
RL   Am. J. Hum. Genet. 89:464-473(2011).
CC   -!- FUNCTION: Displays low peroxidase activity and is likely to
CC       participate in H(2)O(2) metabolism and peroxidative reactions in
CC       the cardiovascular system. Plays a role in extracellular matrix
CC       formation. {ECO:0000269|PubMed:18929642,
CC       ECO:0000269|PubMed:19590037}.
CC   -!- CATALYTIC ACTIVITY: 2 phenolic donor + H(2)O(2) = 2 phenoxyl
CC       radical of the donor + 2 H(2)O. {ECO:0000269|PubMed:18929642,
CC       ECO:0000269|PubMed:19590037}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group covalently
CC       per subunit.;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.15 mM for H(2)O(2) {ECO:0000269|PubMed:18929642};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:19590037, ECO:0000269|Ref.8}.
CC       Note=Enriched in the peritubular space of fibrotic kidneys.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q92626-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92626-2; Sequence=VSP_031516, VSP_031517;
CC   -!- TISSUE SPECIFICITY: Expressed at higher levels in heart, lung,
CC       ovary, spleen, intestine and placenta, and at lower levels in
CC       liver, colon, pancreas, kidney, thymus, skeletal muscle and
CC       prostate. Expressed in tumors such as melanoma, breast cancer,
CC       ovarian cancer and glioblastoma. A shorter form probably lacking
CC       the signal sequence is found in testis and in EB1 cells undergoing
CC       p53/TP53-dependent apoptosis. {ECO:0000269|PubMed:10441517,
CC       ECO:0000269|PubMed:11103812, ECO:0000269|PubMed:18929642,
CC       ECO:0000269|PubMed:19590037}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal liver and spleen.
CC       {ECO:0000269|PubMed:11103812}.
CC   -!- INDUCTION: By TGFB1 in fibroblasts and up-regulated in apoptotic
CC       cells. {ECO:0000269|PubMed:10441517, ECO:0000269|PubMed:19590037}.
CC   -!- DISEASE: Anterior segment dysgenesis 7 (ASGD7) [MIM:269400]: A
CC       form of anterior segment dysgenesis, a group of defects affecting
CC       anterior structures of the eye including cornea, iris, lens,
CC       trabecular meshwork, and Schlemm canal. Anterior segment
CC       dysgeneses result from abnormal migration or differentiation of
CC       the neural crest derived mesenchymal cells that give rise to
CC       components of the anterior chamber during eye development.
CC       Different anterior segment anomalies may exist alone or in
CC       combination, including iris hypoplasia, enlarged or reduced
CC       corneal diameter, corneal vascularization and opacity, posterior
CC       embryotoxon, corectopia, polycoria, abnormal iridocorneal angle,
CC       ectopia lentis, and anterior synechiae between the iris and
CC       posterior corneal surface. Clinical conditions falling within the
CC       phenotypic spectrum of anterior segment dysgeneses include
CC       aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters
CC       anomaly, and iridogoniodysgenesis. ASGD7 is an autosomal recessive
CC       disease. {ECO:0000269|PubMed:21907015}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00298}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF06354.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA13219.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF200348; AAF06354.1; ALT_INIT; mRNA.
DR   EMBL; EF090903; ABO25865.1; -; mRNA.
DR   EMBL; D86983; BAA13219.1; ALT_INIT; mRNA.
DR   EMBL; CH471053; EAX01084.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX01085.1; -; Genomic_DNA.
DR   EMBL; BC098579; AAH98579.1; -; mRNA.
DR   CCDS; CCDS46221.1; -. [Q92626-1]
DR   RefSeq; NP_036425.1; NM_012293.2. [Q92626-1]
DR   UniGene; Hs.332197; -.
DR   ProteinModelPortal; Q92626; -.
DR   SMR; Q92626; -.
DR   BioGrid; 113596; 24.
DR   IntAct; Q92626; 1.
DR   MINT; MINT-4931004; -.
DR   STRING; 9606.ENSP00000252804; -.
DR   PeroxiBase; 3355; HsPxd01.
DR   iPTMnet; Q92626; -.
DR   PhosphoSitePlus; Q92626; -.
DR   SwissPalm; Q92626; -.
DR   BioMuta; PXDN; -.
DR   DMDM; 172045828; -.
DR   EPD; Q92626; -.
DR   MaxQB; Q92626; -.
DR   PaxDb; Q92626; -.
DR   PeptideAtlas; Q92626; -.
DR   PRIDE; Q92626; -.
DR   DNASU; 7837; -.
DR   Ensembl; ENST00000252804; ENSP00000252804; ENSG00000130508. [Q92626-1]
DR   GeneID; 7837; -.
DR   KEGG; hsa:7837; -.
DR   UCSC; uc002qxa.4; human. [Q92626-1]
DR   CTD; 7837; -.
DR   DisGeNET; 7837; -.
DR   GeneCards; PXDN; -.
DR   HGNC; HGNC:14966; PXDN.
DR   HPA; HPA012375; -.
DR   MalaCards; PXDN; -.
DR   MIM; 269400; phenotype.
DR   MIM; 605158; gene.
DR   neXtProt; NX_Q92626; -.
DR   OpenTargets; ENSG00000130508; -.
DR   Orphanet; 289499; Congenital cataract microcornea with corneal opacity.
DR   PharmGKB; PA128394535; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   eggNOG; ENOG410XPZ3; LUCA.
DR   GeneTree; ENSGT00550000074325; -.
DR   HOGENOM; HOG000016084; -.
DR   HOVERGEN; HBG108312; -.
DR   InParanoid; Q92626; -.
DR   KO; K19511; -.
DR   OMA; VMIPPND; -.
DR   OrthoDB; EOG091G0236; -.
DR   PhylomeDB; Q92626; -.
DR   TreeFam; TF314316; -.
DR   BRENDA; 1.11.1.7; 2681.
DR   ChiTaRS; PXDN; human.
DR   GeneWiki; PXDN; -.
DR   GenomeRNAi; 7837; -.
DR   PRO; PR:Q92626; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000130508; -.
DR   CleanEx; HS_PRG2; -.
DR   CleanEx; HS_PXDN; -.
DR   ExpressionAtlas; Q92626; baseline and differential.
DR   Genevisible; Q92626; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005152; F:interleukin-1 receptor antagonist activity; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004601; F:peroxidase activity; IDA:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; IDA:UniProtKB.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   Gene3D; 1.10.640.10; -; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR032675; L_dom-like.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF07679; I-set; 4.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF00093; VWC; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 4.
DR   SMART; SM00369; LRR_TYP; 5.
DR   SMART; SM00082; LRRCT; 1.
DR   SMART; SM00214; VWC; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   SUPFAM; SSF48726; SSF48726; 4.
DR   SUPFAM; SSF52058; SSF52058; 1.
DR   PROSITE; PS50835; IG_LIKE; 4.
DR   PROSITE; PS51450; LRR; 5.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Disease mutation;
KW   Disulfide bond; Extracellular matrix; Glycoprotein; Heme;
KW   Hydrogen peroxide; Immunoglobulin domain; Iron; Leucine-rich repeat;
KW   Metal-binding; Oxidoreductase; Peroxidase; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27   1479       Peroxidasin homolog.
FT                                /FTId=PRO_0000319619.
FT   DOMAIN       27     63       LRRNT.
FT   REPEAT       87    108       LRR 1.
FT   REPEAT      111    132       LRR 2.
FT   REPEAT      135    156       LRR 3.
FT   REPEAT      159    180       LRR 4.
FT   DOMAIN      192    245       LRRCT.
FT   DOMAIN      246    332       Ig-like C2-type 1.
FT   DOMAIN      342    428       Ig-like C2-type 2.
FT   DOMAIN      433    520       Ig-like C2-type 3.
FT   DOMAIN      521    610       Ig-like C2-type 4.
FT   DOMAIN     1413   1471       VWFC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00220}.
FT   ACT_SITE    827    827       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       828    828       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       907    907       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       909    909       Calcium; via carbonyl oxygen.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   METAL       911    911       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL       913    913       Calcium. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   METAL      1074   1074       Iron (heme axial ligand).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   BINDING     826    826       Heme (covalent; via 2 links).
FT                                {ECO:0000250}.
FT   BINDING     980    980       Heme (covalent; via 2 links).
FT                                {ECO:0000250}.
FT   SITE        977    977       Transition state stabilizer.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   MOD_RES    1176   1176       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   MOD_RES    1180   1180       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008}.
FT   CARBOHYD    640    640       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    699    699       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    719    719       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    731    731       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    865    865       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1178   1178       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1280   1280       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1368   1368       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1425   1425       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    267    317       {ECO:0000250}.
FT   DISULFID    363    412       {ECO:0000250}.
FT   DISULFID    454    502       {ECO:0000250}.
FT   DISULFID    546    594       {ECO:0000250}.
FT   DISULFID    732    748       {ECO:0000250}.
FT   DISULFID    847    857       {ECO:0000250}.
FT   DISULFID    851    875       {ECO:0000250}.
FT   DISULFID    959    970       {ECO:0000250}.
FT   DISULFID   1177   1234       {ECO:0000250}.
FT   DISULFID   1275   1301       {ECO:0000250}.
FT   VAR_SEQ     703    727       YHYNDLVSPQYLNLIANLSGCTAHR -> QCQSLFFLLHGL
FT                                SNGVEHASVKSHS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031516.
FT   VAR_SEQ     728   1479       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031517.
FT   VARIANT     880    880       R -> C (in ASGD7; dbSNP:rs587777572).
FT                                {ECO:0000269|PubMed:21907015}.
FT                                /FTId=VAR_071389.
FT   VARIANT    1198   1198       R -> Q (in dbSNP:rs6723697).
FT                                /FTId=VAR_050487.
FT   VARIANT    1261   1261       Q -> R (in dbSNP:rs6723697).
FT                                /FTId=VAR_039048.
SQ   SEQUENCE   1479 AA;  165275 MW;  7A75F533D89C6AAD CRC64;
     MAKRSRGPGR RCLLALVLFC AWGTLAVVAQ KPGAGCPSRC LCFRTTVRCM HLLLEAVPAV
     APQTSILDLR FNRIREIQPG AFRRLRNLNT LLLNNNQIKR IPSGAFEDLE NLKYLYLYKN
     EIQSIDRQAF KGLASLEQLY LHFNQIETLD PDSFQHLPKL ERLFLHNNRI THLVPGTFNH
     LESMKRLRLD SNTLHCDCEI LWLADLLKTY AESGNAQAAA ICEYPRRIQG RSVATITPEE
     LNCERPRITS EPQDADVTSG NTVYFTCRAE GNPKPEIIWL RNNNELSMKT DSRLNLLDDG
     TLMIQNTQET DQGIYQCMAK NVAGEVKTQE VTLRYFGSPA RPTFVIQPQN TEVLVGESVT
     LECSATGHPP PRISWTRGDR TPLPVDPRVN ITPSGGLYIQ NVVQGDSGEY ACSATNNIDS
     VHATAFIIVQ ALPQFTVTPQ DRVVIEGQTV DFQCEAKGNP PPVIAWTKGG SQLSVDRRHL
     VLSSGTLRIS GVALHDQGQY ECQAVNIIGS QKVVAHLTVQ PRVTPVFASI PSDTTVEVGA
     NVQLPCSSQG EPEPAITWNK DGVQVTESGK FHISPEGFLT INDVGPADAG RYECVARNTI
     GSASVSMVLS VNVPDVSRNG DPFVATSIVE AIATVDRAIN STRTHLFDSR PRSPNDLLAL
     FRYPRDPYTV EQARAGEIFE RTLQLIQEHV QHGLMVDLNG TSYHYNDLVS PQYLNLIANL
     SGCTAHRRVN NCSDMCFHQK YRTHDGTCNN LQHPMWGASL TAFERLLKSV YENGFNTPRG
     INPHRLYNGH ALPMPRLVST TLIGTETVTP DEQFTHMLMQ WGQFLDHDLD STVVALSQAR
     FSDGQHCSNV CSNDPPCFSV MIPPNDSRAR SGARCMFFVR SSPVCGSGMT SLLMNSVYPR
     EQINQLTSYI DASNVYGSTE HEARSIRDLA SHRGLLRQGI VQRSGKPLLP FATGPPTECM
     RDENESPIPC FLAGDHRANE QLGLTSMHTL WFREHNRIAT ELLKLNPHWD GDTIYYETRK
     IVGAEIQHIT YQHWLPKILG EVGMRTLGEY HGYDPGINAG IFNAFATAAF RFGHTLVNPL
     LYRLDENFQP IAQDHLPLHK AFFSPFRIVN EGGIDPLLRG LFGVAGKMRV PSQLLNTELT
     ERLFSMAHTV ALDLAAINIQ RGRDHGIPPY HDYRVYCNLS AAHTFEDLKN EIKNPEIREK
     LKRLYGSTLN IDLFPALVVE DLVPGSRLGP TLMCLLSTQF KRLRDGDRLW YENPGVFSPA
     QLTQIKQTSL ARILCDNADN ITRVQSDVFR VAEFPHGYGS CDEIPRVDLR VWQDCCEDCR
     TRGQFNAFSY HFRGRRSLEF SYQEDKPTKK TRPRKIPSVG RQGEHLSNST SAFSTRSDAS
     GTNDFREFVL EMQKTITDLR TQIKKLESRL STTECVDAGG ESHANNTKWK KDACTICECK
     DGQVTCFVEA CPPATCAVPV NIPGACCPVC LQKRAEEKP
//
